E Smit
Overview
Explore the profile of E Smit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
2035
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smit E, Leenaars K, Wagemakers M, Bakker E, Velden J, Molleman G
PLoS One
. 2023 Dec;
18(12):e0287913.
PMID: 38096146
Introduction: Care Sport Connectors (CSCs) have been appointed to create a connection between the primary care and physical activity (PA) sectors to stimulate residents who are inactive to become more...
2.
Caiment F, Wolters J, Smit E, Schrooders Y, Kleinjans J, van den Beucken T
Arch Toxicol
. 2020 Jul;
94(10):3463-3473.
PMID: 32623605
Valproic acid (VPA) is a frequently prescribed anti-epileptic drug which is known to cause liver toxicity and steatosis through mitochondrial dysfunction. Nevertheless the mechanisms underlying these adverse effects are incompletely...
3.
Volschenk C, Ikenaka Y, Yohannes Y, Nakayama S, Ishizuka M, Smit E, et al.
Pestic Biochem Physiol
. 2019 Apr;
156:44-55.
PMID: 31027580
The use of 1,1'-(2,2,2-Trichloro-1,1-ethanediyl)bis(4-chlorobenzene) (DDT) as a pesticide for the control of insects vectors responsible for the spread of many life threatening diseases was officially banned in 1972 by the...
4.
Peters S, Dafni U, Boyer M, De Ruysscher D, Faivre-Finn C, Felip E, et al.
Ann Oncol
. 2019 Jan;
30(2):161-165.
PMID: 30624547
No abstract available.
5.
Munang M, Smit E, Barnett T, Atherton C, Tahir M, Atabani S
Public Health
. 2018 Nov;
166:40-44.
PMID: 30448691
Objectives: In UK laboratories, the diagnostic algorithm for chronic hepatitis C (HCV) infection commonly requires two serological assays to confirm anti-HCV-antibody positivity in a serum sample followed by HCV RNA...
6.
Soria J, Fulop A, Maciel C, Fischer J, Girotto G, Lago S, et al.
Ann Oncol
. 2017 Oct;
28(12):3028-3036.
PMID: 29045535
Background: Combination of selumetinib plus docetaxel provided clinical benefit in a previous phase II trial for patients with KRAS-mutant advanced non-small-cell lung cancer (NSCLC). The phase II SELECT-2 trial investigated...
7.
Leenaars K, van der Velden-Bollemaat E, Smit E, Wagemakers A, Molleman G, Koelen M
Health Promot Int
. 2017 Mar;
33(4):622-634.
PMID: 28334765
To stimulate physical activity (PA) and guide primary care patients towards local sport facilities, Care Sport Connectors (CSCs), to whom a broker role has been ascribed, were introduced in 2012...
8.
Garvey M, Bradley C, Holden K, Hewins P, Ngui S, Tedder R, et al.
J Hosp Infect
. 2017 Feb;
96(2):157-162.
PMID: 28196726
Background: Hepatitis C virus (HCV) infection is a major health burden worldwide. A patient with no history of HCV infection while on a renal unit was found to seroconvert to...
9.
Leenaars K, Smit E, Wagemakers A, Molleman G, Koelen M
Health Promot Int
. 2016 Dec;
33(3):422-435.
PMID: 28011656
Introduction: To stimulate physical activity and guide primary care patients towards local sport facilities, Care Sport Connectors (CSC), to whom a broker role has been ascribed, were introduced in 2012...
10.
Tostevin A, White E, Dunn D, Croxford S, Delpech V, Williams I, et al.
HIV Med
. 2016 Aug;
18(3):204-213.
PMID: 27476929
Objectives: Transmission of drug-resistant HIV-1 has decreased in the UK since the early 2000s. This analysis reports recent trends and characteristics of transmitted drug resistance (TDR) in the UK from...